These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 26849060)
21. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age. Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077 [TBL] [Abstract][Full Text] [Related]
22. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
23. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. Bussmann H; Wester CW; Thomas A; Novitsky V; Okezie R; Muzenda T; Gaolathe T; Ndwapi N; Mawoko N; Widenfelt E; Moyo S; Musonda R; Mine M; Makhema J; Moffat H; Essex M; Degruttola V; Marlink RG J Acquir Immune Defic Syndr; 2009 May; 51(1):37-46. PubMed ID: 19282782 [TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis. Kanters S; Socias ME; Paton NI; Vitoria M; Doherty M; Ayers D; Popoff E; Chan K; Cooper DA; Wiens MO; Calmy A; Ford N; Nsanzimana S; Mills EJ Lancet HIV; 2017 Oct; 4(10):e433-e441. PubMed ID: 28784426 [TBL] [Abstract][Full Text] [Related]
25. [Efficacy of initial antiretroviral therapy based on lopinavir/ritonavir plus 2 nucleoside/nucleotide analogs in patients with human immunodeficiency virus type 1 infection]. Zamora L; Gatell JM Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():2-6. PubMed ID: 25542868 [TBL] [Abstract][Full Text] [Related]
26. Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS. Shey MS; Kongnyuy EJ; Alobwede SM; Wiysonge CS Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD005481. PubMed ID: 23543540 [TBL] [Abstract][Full Text] [Related]
27. Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial. Pulido F; Ribera E; Lagarde M; Pérez-Valero I; Palacios R; Iribarren JA; Payeras A; Domingo P; Sanz J; Cervero M; Curran A; Rodríguez-Gómez FJ; Téllez MJ; Ryan P; Barrufet P; Knobel H; Rivero A; Alejos B; Yllescas M; Arribas JR; Clin Infect Dis; 2017 Nov; 65(12):2112-2118. PubMed ID: 29020293 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children. Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672 [TBL] [Abstract][Full Text] [Related]
29. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial. Arribas JR; Girard PM; Landman R; Pich J; Mallolas J; Martínez-Rebollar M; Zamora FX; Estrada V; Crespo M; Podzamczer D; Portilla J; Dronda F; Iribarren JA; Domingo P; Pulido F; Montero M; Knobel H; Cabié A; Weiss L; Gatell JM; Lancet Infect Dis; 2015 Jul; 15(7):785-92. PubMed ID: 26062880 [TBL] [Abstract][Full Text] [Related]
30. Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice. Lackey P; Mills A; Carpio F; Hsu R; DeJesus E; Pierone G; Henegar C; Fusco J; Fusco G; Wohlfeiler M Clin Drug Investig; 2017 Jan; 37(1):51-60. PubMed ID: 27587070 [TBL] [Abstract][Full Text] [Related]
31. Darunavir: a review of its use in the management of HIV infection in adults. McKeage K; Perry CM; Keam SJ Drugs; 2009; 69(4):477-503. PubMed ID: 19323590 [TBL] [Abstract][Full Text] [Related]
32. [Positioning of lopinavir/ritonavir in antiretroviral treatment schemes]. Camacho Á; Rivero A Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():31-4. PubMed ID: 25542874 [TBL] [Abstract][Full Text] [Related]
33. 48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis. Patel DA; Snedecor SJ; Tang WY; Sudharshan L; Lim JW; Cuffe R; Pulgar S; Gilchrist KA; Camejo RR; Stephens J; Nichols G PLoS One; 2014; 9(9):e105653. PubMed ID: 25188312 [TBL] [Abstract][Full Text] [Related]
34. Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss. van Vonderen MG; van Agtmael MA; Hassink EA; Milinkovic A; Brinkman K; Geerlings SE; Ristola M; van Eeden A; Danner SA; Reiss P; PLoS One; 2009 May; 4(5):e5647. PubMed ID: 19479079 [TBL] [Abstract][Full Text] [Related]
35. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Hakim JG; Thompson J; Kityo C; Hoppe A; Kambugu A; van Oosterhout JJ; Lugemwa A; Siika A; Mwebaze R; Mweemba A; Abongomera G; Thomason MJ; Easterbrook P; Mugyenyi P; Walker AS; Paton NI; Lancet Infect Dis; 2018 Jan; 18(1):47-57. PubMed ID: 29108797 [TBL] [Abstract][Full Text] [Related]